Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FenHydro Trial
NCT07224620Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Nov 2025
- Primary completion
- May 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fentanyl, hydromorphone in respiratory failure, sponsored by Beth Israel Deaconess Medical Center. Started Nov 2025; status: completed.
02
Drugs
fentanylhydromorphone
03
Conditions
respiratory failure
Beyond the preview
Go deeper on NCT07224620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07224620.